News Daily News BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease L.A. McKeown May 01, 2023
News Daily News Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA Shelley Wood April 25, 2023
News Daily News Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI Michael O'Riordan March 31, 2023
News Daily News PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI L.A. McKeown March 29, 2023
News Daily News MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter Yael L. Maxwell March 27, 2023
News Daily News Small Improvements in Fitness Add Up to Big Mortality Gains, Study Finds L.A. McKeown March 20, 2023
News Daily News Worse CABG Outcomes in Women Haven’t Budged in Over a Decade: STS L.A. McKeown March 03, 2023
News Daily News Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis Michael O'Riordan February 24, 2023
News Daily News For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI Michael O'Riordan February 23, 2023
News Daily News Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men Yael L. Maxwell February 21, 2023
News Daily News Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM Yael L. Maxwell February 15, 2023
News Daily News Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL Michael O'Riordan February 15, 2023
News Daily News Upstream Care Lacking for Many CTO PCI Patients in VA Health System Yael L. Maxwell February 08, 2023
News Daily News Prehospital Troponin Testing With EMS Input Could Save a Lot of Money Michael O'Riordan February 07, 2023
News Daily News REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD L.A. McKeown January 24, 2023
News Daily News Brachytherapy Remains an Option for DES In-Stent Restenosis Yael L. Maxwell January 12, 2023
News Daily News CT Angiography Is Increasing in England, but Downstream Tests Are Not Michael O'Riordan January 12, 2023
News Daily News Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees Michael O'Riordan January 05, 2023